World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33529294

Number of visits today: 7000

Number of downloads: 16715381

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Takeda T, Sasaki T, Okamoto T, Kasuga A, Matsuyama M, Ozaka M, Inoue Y, Takahashi Y, Saiura A, Sasahira N. Outcomes of pancreatic cancer with liver oligometastasis. J Hepatobiliary Pancreat Sci 2023;30:229-39. [PMID: 35593731 DOI: 10.1002/jhbp.1184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Takeda T, Sasaki T, Okamoto T, Kasuga A, Matsuyama M, Ozaka M, Inoue Y, Takahashi Y, Saiura A, Sasahira N. Outcomes of pancreatic cancer with liver oligometastasis. J Hepatobiliary Pancreat Sci 2023;30:229-39. [PMID: 35593731 DOI: 10.1002/jhbp.1184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	Mie T, Sasaki T, Okamoto T, Takeda T, Mori C, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N. Treatment outcomes of nanoliposomal irinotecan as second-line chemotherapy after gemcitabine and nab-paclitaxel in metastatic and recurrent pancreatic cancer. Jpn J Clin Oncol 2022;52:1399-407. [PMID: 36111430 DOI: 10.1093/jjco/hyac145] [Reference Citation Analysis]

Number

Citing Articles

Mie T, Sasaki T, Okamoto T, Takeda T, Mori C, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N. Treatment outcomes of nanoliposomal irinotecan as second-line chemotherapy after gemcitabine and nab-paclitaxel in metastatic and recurrent pancreatic cancer. Jpn J Clin Oncol 2022;52:1399-407. [PMID: 36111430 DOI: 10.1093/jjco/hyac145] [Reference Citation Analysis]